Cargando…
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
MYC is a key oncogenic driver in multiple tumor types, but concomitantly endows cancer cells with a series of vulnerabilities that provide opportunities for targeted pharmacological intervention. For example, drugs that suppress mitochondrial respiration selectively kill MYC‐overexpressing cells. He...
Autores principales: | Donati, Giulio, Nicoli, Paola, Verrecchia, Alessandro, Vallelonga, Veronica, Croci, Ottavio, Rodighiero, Simona, Audano, Matteo, Cassina, Laura, Ghsein, Aya, Binelli, Giorgio, Boletta, Alessandra, Mitro, Nico, Amati, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245039/ https://www.ncbi.nlm.nih.gov/pubmed/37158102 http://dx.doi.org/10.15252/emmm.202216910 |
Ejemplares similares
-
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
por: Donati, Giulio, et al.
Publicado: (2021) -
The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
por: D'Andrea, Aleco, et al.
Publicado: (2016) -
Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas
por: Tonelli, C, et al.
Publicado: (2017) -
MYC and therapy resistance in cancer: risks and opportunities
por: Donati, Giulio, et al.
Publicado: (2022) -
Transcriptional integration of mitogenic and mechanical signals by Myc and YAP
por: Croci, Ottavio, et al.
Publicado: (2017)